Andriy Bolbat

Andriy Bolbat, PhD, is a Clinical Project Manager and Regulatory Medical Writer at BIOMEX since November 2021, specializing in clinical performance evaluation for In Vitro Diagnostics and regulatory affairs, with expertise in quality management standards such as ISO 20196, ISO 14155, ISO 9001, ISO 17025, and ISO 13485. Previously, Andriy served as a Doctorate Researcher at EMBL from September 2014 to November 2019, focusing on fluorescence microscopy and cell biology, and completed a thesis on a novel genetically encoded FRET sensor for detecting RNA of the Hepatitis C Virus. Andriy holds a PhD in Molecular Biology from Heidelberg University (2015-2019) and a diploma with honors in Bioorganic Chemistry from Lomonosov Moscow State University (2009-2014).